Post Profile






$250K Grant Supports Examination of Drug Compound on Common Cancer Mutation

A $250,000 grant from the Breast Cancer Research Foundation awarded to a Rutgers Cancer Institute of New Jersey researcher will help further elucidate the inner workings of the p53 gene. The work will examine a drug compound that restores tumor suppressor function, with an aim of providing a foundation for the development of a new type of anti-cancer drug.
read more

share
See more about: Cancer Institute New Jersey

Related Posts


Rutgers Cancer Institute of New Jersey Researchers Awarded Nearly $2.5M to Examine Ways to Block Cancer Cell Growth

Health : Newswise Medical News

A pair of researchers at Rutgers Cancer Institute of New Jersey has been awarded nearly $2.5 million dollars from the National Institutes of Health to further study in their respective laboratories. X.F. Steven Zheng, PhD, was award...

Rutgers Cancer Institute of New Jersey Researcher Awarded Grant to Identify New Treatments for Aggressive Breast Cancers

Health : Newswise Medical News

A physician-scientist from Rutgers Cancer Institute of New Jersey who is studying ways to advance the molecular understanding of breast cancer has received a $181,000 grant to further this research with the aim of identifying new tr...

$200K Grant to Cancer Institute of New Jersey Researcher Enables Further Study of Drug Compound that Restores Tumor Suppressor Function in p53 Gene

Health : Newswise Medical News

Darren Carpizo, MD, PhD, a surgical oncologist in the Liver Cancer and Bile Duct Cancer Care Program at the Cancer Institute of New Jersey, has been awarded a $200,000 grant from the Sidney Kimmel Foundation for Cancer Research to f...

Rutgers Cancer Researchers Examine Gene Fusion and Treatment Implications for Breast Cancer

Health : Newswise Medical News

The Breast Cancer Research Foundation has awarded a pair of investigators at Rutgers Cancer Institute of New Jersey a one-year, $240,000 grant to examine treatment implications for a genetic variation found in a quarter of Caucasian...

$1.8M Supports Further Exploration of Drug Compound on Commonly Mutated Gene

Health : Newswise Medical News

A Rutgers Cancer Institute of New Jersey researcher has been awarded a $1.8-million grant from the National Cancer Institute to build upon research examining a drug compound that restores tumor suppressor function in the most common...

Comments


Copyright © 2016 Regator, LLC